Advisory panel speaks out against proposed decrease in separately payable drug reimbursement for 2009
Briefings on APCs, December 1, 2008
This is an excerpt from a member only article. To read the article in its entirety, please login or subscribe to Briefings on APCs.
One of the more controversial provisions of the 2009 OPPS proposed rule is CMS’ plan to reduce drug reimbursement for separately payable drugs from the current average sales price (ASP) plus 5% to ASP plus 4%.
This is an excerpt from a member only article. To read the article in its entirety, please login or subscribe to Briefings on APCs.
Comments
0 comments on “Advisory panel speaks out against proposed decrease in separately payable drug reimbursement for 2009 ”
Related Products
Most Popular
- Articles
-
- HIPAA Q&A: Flu shot requirement for hospital employees
- Running an effective peer review committee meeting
- HealthDataInsights posts new issues for medical necessity claims
- Sneak Peek: Effort underway to establish caseload benchmarks
- Q/A: Coding for telescopic intraocular lens
- New FAQ posted on storing laryngoscope blades
- Tip: Perform your own internal investigation prior to government audit
- HIPAA 5010 deadline extended, but threat remains, says AMA
- HHS task force: Consider privacy, security with text messages
- What does case-mix index mean to you?
- E-mailed
-
- Running an effective peer review committee meeting
- HIPAA Q&A: Flu shot requirement for hospital employees
- HHS task force: Consider privacy, security with text messages
- What does case-mix index mean to you?
- Q/A: Coding for telescopic intraocular lens
- Q/A: Correct use of modifier -PT
- Tip: Correctly code bilateral pain management procedures
- "Wall fountains" may be spreading Legionnaires to patients, visitors
- 2012 CPT code changes for ASCs: Shoulder and knee scopes and pain management
- Case Management Monthly, March 2012
- Searched
